| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 7e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-07 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.24 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 1e-08 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.26 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.27 | 0.3 |